ASA issues ruling against misleading hyperbaric oxygen therapy promo
The Advertising Standards Authority (ASA) has upheld a claim against a provider of hyperbaric oxygen therapy after its website made misleading claims about the treatment.
The Advertising Standards Authority (ASA) has upheld a claim against a provider of hyperbaric oxygen therapy after its website made misleading claims about the treatment.
A deep dive into the advertising rules surrounding botulinum toxin and other prescription-only medicines in the UK
The Advertising Standards Authority (ASA) has issued a ruling against a television advertisement from Braun which claimed their at-home intense pulsed light (IPL) device could lead to ‘permanent’ hair removal.
The Advertising Standards Authority (ASA) has issued a ruling against an aesthetic clinic after it posted promotional material about a celebrity botulinum toxin procedure.
The Advertising Standards Authority (ASA) has issued three separate rulings against aesthetic clinics which had been advertising sclerotherapy treatments.
The Advertising Standards Authority (ASA) has issued a ruling against an aesthetic and wellness clinic following longevity claims in advertisements.
The Advertising Standards Authority (ASA) has issued a ruling against aesthetic treatment comparison site Glowday, after it posted content advertising botulinum toxin to the public.
The Committees of Advertising Practice (CAP) from the Advertising Standards Authority (ASA) has issued updated guidance on how influencers are able to promote products and services on social media.
The Advertising Standards Authority (ASA) has issued a ruling against an online supplement provider based in Leeds after it advertised prescription-only hair loss medication to the public.
The Advertising Standards Authority (ASA) has upheld a complaint against an aesthetic clinic after they released two advertisements promoting prescription-only hydrocortisone injections.